Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Diseases × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 22 Breast Neoplasms 14 Myelodysplastic Syndromes 9 Stomach Neoplasms 8 Leukemia, Myelomonocytic, Chronic 7 Sarcoma 6 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Non-Small-Cell Lung 5 Uterine Cervical Neoplasms 4 Recurrence 4 Neoplasms 4 Melanoma 4 Leukemia, Monocytic, Acute 4 Head and Neck Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Advanced Solid Tumour 4 Stomatitis 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Mucositis 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2

Interventions

atezolizumab 2 Sorafenib 2 Bevacizumab 2 titanium silicide 1 ledipasvir, sofosbuvir drug combination 1 halofantrine 1 genexol-PM 1 durvalumab 1 Sunitinib 1 Ramucirumab 1 Neoadjuvant Therapy 1 N-monoacetylcystine 1 Leucovorin 1 Injections 1 Immunotherapy 1 Formyltetrahydrofolates 1 Everolimus 1 Cisplatin 1 Catheter Ablation 1 Adjuvants, Pharmaceutic 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡